The Times
.

More Articles ...

  1. Henkel kicks off its anniversary year 2026
  2. The Jollibee Group Announces Continued Momentum in Coffee and Tea and Chinese Cuisine Segments
  3. C Capital Acquires 507 Hectares of Landholding in Australia
  4. Taikang Asset (HK) launches its first HKD and USD Money Market ETFs
  5. Premier International Ophthalmology Congress, APAO 2026, to be Held in Hong Kong this February
  6. HKCERT Releases "Hong Kong Cybersecurity Outlook 2026" Security Incidents Hit Record High with 27% Annual Increase
  7. IET’s First International Conference on Digital Twins and Applications Concludes at Hong Kong PolyU, Highlighting the Transformative Power of Digital Twin Technology
  8. Asian Financial Forum concludes successfully in Hong Kong, gathering over 4,000 global business leaders and officials
  9. Citi Enriches Private Market Offerings for Citigold Private Clients in Collaboration with Blackstone, Blue Owl and KKR
  10. GalaxyArt Shines with the Macau Debut Exhibition of Copper Art Maestro Zhu Bingren
  11. UnionPay Enables 25 International Wallets to Support Weixin Pay QR Code in China’ Mainland
  12. M8 World Championship breaks ground in Türkiye as Mobile Legends: Bang Bang charts global ambitions with five-region esports overhaul
  13. Beyond Range, The VF 8 and VinFast's Formula for Long-Distance Electric Endurance
  14. Fuel Incorporation Announces Global Expansion into International Oil Brokerage and Bunkering
  15. Speed Recognised with BrandLaureate DigiTech BestBrand Award for Advancing Digital Procurement Excellence
  16. Bodor Laser Introduces the "Extreme Speed" Concept in Tube Processing, Launches the SK Series High-Speed Tube Laser Cutting Machine
  17. Southco Expands Southeast Asia Footprint With Chon Buri Facility Opening
  18. AsiaPac and AsiaPay Forge Strategic Partnership to Launch a Unified "Marketing-plus-Payment" Growth Engine for Asia
  19. SMU Launches Resilient Workforces Institute to Strengthen Singapore’s Workforce in the Age of AI
  20. Immuno Cure Kicks off Phase I Clinical Study of Therapeutic DNA Vaccine for HIV in Hong Kong